Search results
Pfizer’s First Gene Therapy Gets Approval for Clotting Disorder
Bloomberg· 3 hours agoPfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine...
US FDA approves Pfizer's gene therapy for rare bleeding disorder
Reuters· 3 hours ago, opens new tab gene therapy for hemophilia B on Friday, the second such therapy for the rare...
Pfizer Inc. (PFE) Becoming More Attractive for Investors – Knox Daily
Knox Daily· 4 days agoPfizer Inc.’s recent filing unveils that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at ...
What's Going On With Pfizer Stock On Thursday? By Benzinga
Investing.com· 20 hours agoWhat's Going On With Pfizer Stock On Thursday?
PFE Shares Experience Decline in Value – Knox Daily
Knox Daily· 1 day agoInvestors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Pfizer Inc. shares valued at $79,401 were purchased ...
Electric Boat moves ahead of Pfizer as the town's top taxpayer
The Day, New London, Conn. via Yahoo Finance· 13 hours agoApr. 25—GROTON — Electric Boat is now the town's top taxpayer, jumping ahead of Pfizer, which is now the second-highest taxpayer. The town's grand list of taxable property in 2023 increased ...
J.W. Cole Advisors Inc. Boosts Stake in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 5 days agoJ.W. Cole Advisors Inc. raised its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 25.3% during the fourth quarter, according to its most recent disclosure ...
Pfizer (NYSE:PFE) Trading 0.9% Higher
ETF DAILY NEWS· 5 days agoShares of Pfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.9% during mid-day trading on Friday . The stock traded as high as $25.66 and last traded ...
EU regulators approve Pfizer antibiotic Emblaveo (NYSE:PFE)
Seeking Alpha· 4 days agoEU regulators have approved Pfizer (PFE) and AbbVie’s (ABBV) antibiotic product Emblaveo for the...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters· 24 hours agoGlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of...